Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-25

FDA Approved: TOSYMRA — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved Tosymra, a nasal spray formulation of sumatriptan from Upsher-Smith, via an original NDA for the acute treatment of migraine with or without aura i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOSYMRA (Sumatriptan)

Snippet

ORIG AP for TOSYMRA (SUMATRIPTAN)